Valuation: AstraZeneca PLC

Capitalization 207B 195B 182B 162B 290B 17,501B 321B 2,247B 833B 7,170B 775B 759B 31,018B P/E ratio 2024 *
24.5x
P/E ratio 2025 * 20.3x
Enterprise value 229B 217B 202B 180B 322B 19,417B 356B 2,492B 925B 7,954B 860B 842B 34,414B EV / Sales 2024 *
4.32x
EV / Sales 2025 * 3.93x
Free-Float
96.63%
Yield 2024 *
2.33%
Yield 2025 * 2.45%
More valuation ratios * Estimated data
Dynamic Chart
1 day+0.97%
1 week+0.23%
Current month+0.06%
1 month+4.98%
3 months-15.33%
6 months-15.16%
Current year+0.17%
More quotes
1 week
10 416.00
Extreme 10416
10 804.00
1 month
9 670.00
Extreme 9670
10 804.00
Current year
9 461.00
Extreme 9461
13 388.00
1 year
9 461.00
Extreme 9461
13 388.00
3 years
8 090.32
Extreme 8090.32
13 388.00
5 years
5 871.00
Extreme 5871
13 388.00
10 years
3 680.00
Extreme 3680
13 388.00
More quotes
Director TitleAgeSince
Chief Executive Officer 64 30/09/2012
Director of Finance/CFO 50 31/07/2021
Chief Tech/Sci/R&D Officer 56 31/12/2019
Manager TitleAgeSince
Director/Board Member 68 05/04/1999
Director/Board Member 64 30/09/2012
Director/Board Member 63 26/04/2017
More insiders
Add to a list
Change 5d. change 1-year change 3-years change Capi. ($)
+1.32%+0.23%+4.67%+26.96%207B
-0.65%+4.05%+40.71%+235.96%747B
-1.15%+3.13%+12.21%+117.61%487B
-0.89%-3.64%-5.80%-8.33%362B
-0.77%-3.97%+21.51%+44.76%312B
+1.20%+1.16%-3.21%+40.04%256B
+1.02%+0.95%+2.13%-30.27%231B
+0.31%-3.21%+6.25%+21.10%204B
-1.08%-2.45%+1.87%+32.16%150B
+1.21%-2.17%-11.86%-50.19%143B
Average -0.00%-0.41%+6.85%+42.98% 309.88B
Weighted average by Cap. -0.26%+0.85%+13.38%+82.41%
See all sector performances

Financials

2024 *2025 *
Net sales 53.07B 50.21B 46.67B 41.61B 74.46B 4,496B 82.43B 577B 214B 1,842B 199B 195B 7,969B 56.96B 53.89B 50.08B 44.65B 79.91B 4,826B 88.46B 619B 230B 1,977B 214B 209B 8,552B
Net income 8.36B 7.91B 7.35B 6.55B 11.73B 708B 12.98B 90.92B 33.73B 290B 31.38B 30.71B 1,255B 10.15B 9.6B 8.92B 7.95B 14.24B 860B 15.76B 110B 40.93B 352B 38.08B 37.27B 1,523B
Net Debt 22.62B 21.4B 19.89B 17.73B 31.73B 1,916B 35.12B 246B 91.24B 785B 84.89B 83.08B 3,396B 17.01B 16.09B 14.95B 13.33B 23.86B 1,441B 26.41B 185B 68.62B 590B 63.84B 62.48B 2,554B
More financial data * Estimated data
Logo AstraZeneca PLC
AstraZeneca PLC is one of the world's leading pharmaceutical groups. Net sales break down by source of income as follows: - product sales (95.6%). Net sales break down by treatment area between oncology (39.2%), cardiovascular, renal and metabolic diseases (24.2%), respiratory and autoimmune diseases (13.9%), and other (22.7%; inflammatory diseases, neurological diseases, gastrointestinal and infectious diseases); - collaboration revenue (4.4%). Net sales are distributed geographically as follows: the United Kingdom (7.4%), Europe (21.2%), America (45.3%) and Africa-Asia-Australia (26.1%).
Employees
89,900
Calendar
More about the company
Date Price Change Volume
05/12/24 10,618.00 p +1.32% 1,458,917
04/12/24 10,480.00 p -2.87% 4,060,643
03/12/24 10,790.00 p +2.24% 2,193,681
02/12/24 10,554.00 p -0.55% 1,931,094
29/11/24 10,612.00 p +0.17% 2,380,553

Delayed Quote London S.E., December 05, 2024 at 04:35 pm

More quotes
Trading Rating
Investor Rating
ESG Refinitiv
B+
surperformance-ratings-light-chart ASTRAZENECA-PLCMore Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
20
Last Close Price
133.26USD
Average target price
177.00USD
Spread / Average Target
+32.83%
Consensus

Quarterly revenue - Rate of surprise